tradingkey.logo

West Pharmaceutical Services Inc

WST

209.483USD

-1.807-0.86%
交易中 美東報價延遲15分鐘
15.04B總市值
30.53本益比TTM

West Pharmaceutical Services Inc

209.483

-1.807-0.86%
關於 West Pharmaceutical Services Inc 公司
West Pharmaceutical Services, Inc. 是一家全球製造商,致力於設計和生產技術先進的注射藥物和保健產品集成容器和輸送系統。公司通過兩個部門運營:專有產品和合同製造產品。專有產品部門主要向生物、仿製藥和製藥客戶提供包裝、容器解決方案和藥物輸送產品,以及分析實驗室服務和其他集成服務和解決方案。合同製造產品部門是一家完全整合的企業,專注於複雜設備的設計、製造和自動化組裝,主要面向製藥、診斷和醫療設備客戶。該部門製造用於外科、診斷、眼科、注射和其他藥物輸送系統以及消費產品的客戶自有組件和設備。
公司簡介
公司代碼WST
公司名稱West Pharmaceutical Services Inc
上市日期Jul 27, 1923
成立日期1923
CEOMr. Eric Mark Green
員工數量10600
證券類型Ordinary Share
年結日Jul 27
公司地址530 Herman O. West Drive
城市EXTON
上市交易所NYSE Consolidated
國家United States of America
郵編19341
電話16105942900
網址https://www.westpharma.com/
公司代碼WST
上市日期Jul 27, 1923
成立日期1923
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Eric Mark Green
Mr. Eric Mark Green
Non-Independent Chairman of the Board, President, Chief Executive Officer
Non-Independent Chairman of the Board, President, Chief Executive Officer
171.12K
+1.58%
Mr. Douglas A. Michels
Mr. Douglas A. Michels
Independent Director
Independent Director
43.90K
+0.43%
Mr. Thomas W. (Tom) Hofmann
Mr. Thomas W. (Tom) Hofmann
Independent Director
Independent Director
41.87K
+0.43%
Mr. Mark A. Buthman
Mr. Mark A. Buthman
Independent Director
Independent Director
41.73K
+0.42%
Ms. Annette F. Favorite
Ms. Annette F. Favorite
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
21.84K
+4.40%
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Independent Director
Independent Director
17.94K
+0.61%
Mr. Paolo Pucci
Mr. Paolo Pucci
Independent Director
Independent Director
9.39K
+0.88%
Mr. Bernard John Birkett
Mr. Bernard John Birkett
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
7.54K
+9.37%
Mr. Robert F. (Rob) Friel
Mr. Robert F. (Rob) Friel
Lead Independent Director
Lead Independent Director
3.07K
+2.06%
Ms. Kimberly Banks Mackay
Ms. Kimberly Banks Mackay
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
1.51K
+11.48%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Eric Mark Green
Mr. Eric Mark Green
Non-Independent Chairman of the Board, President, Chief Executive Officer
Non-Independent Chairman of the Board, President, Chief Executive Officer
171.12K
+1.58%
Mr. Douglas A. Michels
Mr. Douglas A. Michels
Independent Director
Independent Director
43.90K
+0.43%
Mr. Thomas W. (Tom) Hofmann
Mr. Thomas W. (Tom) Hofmann
Independent Director
Independent Director
41.87K
+0.43%
Mr. Mark A. Buthman
Mr. Mark A. Buthman
Independent Director
Independent Director
41.73K
+0.42%
Ms. Annette F. Favorite
Ms. Annette F. Favorite
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
21.84K
+4.40%
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Independent Director
Independent Director
17.94K
+0.61%
收入明細
單位: USD更新時間: 4月6日 週日
單位: USD更新時間: 4月6日 週日
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
High Value Components
1.30B
45.00%
Standard Packaging
636.50M
22.00%
Contract-Manufactured Products
549.71M
19.00%
Delivery Devices
405.05M
14.00%
地區USD
名稱
營收
佔比
United States
1.23B
42.54%
Other European Countries
385.50M
13.32%
Germany
372.50M
12.88%
Other
339.00M
11.72%
Ireland
323.20M
11.17%
France
242.20M
8.37%
業務
地區
業務USD
名稱
營收
佔比
High Value Components
1.30B
45.00%
Standard Packaging
636.50M
22.00%
Contract-Manufactured Products
549.71M
19.00%
Delivery Devices
405.05M
14.00%
股東統計
更新時間: 2月21日 週五
更新時間: 2月21日 週五
持股股東
股東類型
持股股東
股東統計
佔比
The Vanguard Group, Inc.
12.47%
BlackRock Institutional Trust Company, N.A.
5.76%
Brown Advisory
4.55%
State Street Global Advisors (US)
4.52%
Artisan Partners Limited Partnership
4.33%
Other
68.38%
持股股東
股東統計
佔比
The Vanguard Group, Inc.
12.47%
BlackRock Institutional Trust Company, N.A.
5.76%
Brown Advisory
4.55%
State Street Global Advisors (US)
4.52%
Artisan Partners Limited Partnership
4.33%
Other
68.38%
股東類型
股東統計
佔比
Investment Advisor/Hedge Fund
48.42%
Investment Advisor
36.64%
Hedge Fund
4.18%
Pension Fund
3.86%
Research Firm
2.00%
Bank and Trust
1.66%
Sovereign Wealth Fund
1.28%
Insurance Company
0.78%
Individual Investor
0.59%
Other
0.58%
機構持股
更新時間: 1月20日 週一
更新時間: 1月20日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q1
1612
71.77M
99.89%
-1.14M
2024Q4
1626
70.93M
98.10%
-2.28M
2024Q3
1603
70.42M
97.07%
-3.49M
2024Q2
1609
70.03M
96.14%
-3.89M
2024Q1
1617
70.47M
96.25%
-3.65M
2023Q4
1622
70.59M
95.41%
-3.14M
2023Q3
1619
70.63M
95.63%
-3.16M
2023Q2
1600
70.17M
94.52%
-5.10M
2023Q1
1586
71.76M
96.63%
-2.52M
2022Q4
1564
71.37M
96.40%
-822.34K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
8.96M
12.39%
-463.00
-0.01%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
4.14M
5.72%
-38.26K
-0.92%
Dec 31, 2024
Brown Advisory
2.55M
3.53%
+266.49K
+11.66%
Dec 31, 2024
State Street Global Advisors (US)
3.25M
4.49%
+32.27K
+1.00%
Dec 31, 2024
Artisan Partners Limited Partnership
3.11M
4.3%
+44.38K
+1.45%
Dec 31, 2024
AllianceBernstein L.P.
2.59M
3.59%
-11.06K
-0.42%
Dec 31, 2024
Walter Scott & Partners Ltd.
2.42M
3.34%
+40.48K
+1.70%
Dec 31, 2024
Geode Capital Management, L.L.C.
1.78M
2.46%
+38.76K
+2.23%
Dec 31, 2024
Franklin Advisers, Inc.
1.75M
2.42%
-502.73K
-22.29%
Dec 31, 2024
APG Asset Management N.V.
1.44M
1.99%
-871.45K
-37.74%
Dec 31, 2024
查看更多
持股ETF
更新時間: 4月6日 週日
更新時間: 4月6日 週日
機構名稱
佔比
Amplify Weight Loss Drug & Treatment ETF
3.12%
VanEck Morningstar Wide Moat Growth ETF
2.93%
VictoryShares THB Mid Cap ESG ETF
2.42%
VanEck Morningstar Wide Moat ETF
2.08%
American Century Mid Cap Growth Impact ETF
1.5%
Nuveen ESG Mid-Cap Growth ETF
1.41%
Goldman Sachs Future Health Care Equity ETF
1.36%
Invesco S&P 500 Equal Weight Health Care ETF
1.16%
Nuveen ESG Mid-Cap Value ETF
1.13%
Invesco Nasdaq Free Cash Flow Achievers ETF
1.1%
查看更多
Amplify Weight Loss Drug & Treatment ETF
佔比3.12%
VanEck Morningstar Wide Moat Growth ETF
佔比2.93%
VictoryShares THB Mid Cap ESG ETF
佔比2.42%
VanEck Morningstar Wide Moat ETF
佔比2.08%
American Century Mid Cap Growth Impact ETF
佔比1.5%
Nuveen ESG Mid-Cap Growth ETF
佔比1.41%
Goldman Sachs Future Health Care Equity ETF
佔比1.36%
Invesco S&P 500 Equal Weight Health Care ETF
佔比1.16%
Nuveen ESG Mid-Cap Value ETF
佔比1.13%
Invesco Nasdaq Free Cash Flow Achievers ETF
佔比1.1%
分紅派息
近5年累計派現 269.40M 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Jan 28, 2025
WST.NB Interim Cash Dividend of gross USD 0.21 paid on Feb 11, 2025 going ex on Feb 07, 2025
Feb 07, 2025
Feb 11, 2025
Feb 07, 2025
Oct 24, 2024
WST.NB Final Cash Dividend of gross USD 0.21 paid on Nov 20, 2024 going ex on Nov 13, 2024
Nov 13, 2024
Nov 20, 2024
Nov 13, 2024
Apr 25, 2024
WST.NB Interim Cash Dividend of gross USD 0.2 paid on Aug 07, 2024 going ex on Jul 31, 2024
Jul 31, 2024
Aug 07, 2024
Jul 31, 2024
Feb 20, 2024
WST.NB Interim Cash Dividend of gross USD 0.2 paid on May 01, 2024 going ex on Apr 23, 2024
Apr 24, 2024
May 01, 2024
Apr 23, 2024
Dec 06, 2023
WST.NB Interim Cash Dividend of gross USD 0.2 paid on Feb 07, 2024 going ex on Jan 30, 2024
Jan 31, 2024
Feb 07, 2024
Jan 30, 2024
Oct 26, 2023
WST.NB Final Cash Dividend of gross USD 0.2 paid on Nov 15, 2023 going ex on Nov 07, 2023
Nov 08, 2023
Nov 15, 2023
Nov 07, 2023
Apr 27, 2023
WST.NB Interim Cash Dividend of gross USD 0.19 paid on Aug 02, 2023 going ex on Jul 25, 2023
Jul 26, 2023
Aug 02, 2023
Jul 25, 2023
Mar 03, 2023
WST.NB Interim Cash Dividend of gross USD 0.19 paid on May 03, 2023 going ex on Apr 25, 2023
Apr 26, 2023
May 03, 2023
Apr 25, 2023
Dec 13, 2022
WST.NB Interim Cash Dividend of gross USD 0.19 paid on Feb 01, 2023 going ex on Jan 24, 2023
Jan 25, 2023
Feb 01, 2023
Jan 24, 2023
Oct 27, 2022
WST.NB Final Cash Dividend of gross USD 0.19 paid on Nov 16, 2022 going ex on Nov 08, 2022
Nov 09, 2022
Nov 16, 2022
Nov 08, 2022
查看更多
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
tradingkey.logo
tradingkey.logo
日內數據由路孚特(Refinitiv)提供,並受使用條款約束。歷史及當前收盤數據均由路孚特提供。所有報價均以當地交易所時間為準。美股報價的即時最後成交數據僅反映透過納斯達克報告的交易。日內數據延遲至少15分鐘或遵循交易所要求。
* 參考、分析和交易策略由提供商Trading Central提供,觀點基於分析師的獨立評估和判斷,未考慮投資者的投資目標和財務狀況。
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有